PUBLISHER: Grand View Research | PRODUCT CODE: 1841991
PUBLISHER: Grand View Research | PRODUCT CODE: 1841991
The global fertility testing devices market size was estimated at USD 2.47 billion in 2024 and is expected to reach USD 4.71 billion by 2033, growing at a CAGR of 7.50% from 2025 to 2033. Rising awareness about fertility health, delayed parenthood and lifestyle changes, technological advancements in home testing devices, and preference for at-home and non-invasive testing are some of the factors driving industry growth.
Furthermore, the growth of IVF and other ART procedures encourages pre-conception monitoring using fertility devices, thereby escalating market growth. Many women are choosing to start families later due to career priorities, higher education, and personal goals. Delaying parenthood can affect fertility, leading to increased interest in monitoring reproductive health.
The table shows a clear shift toward older maternal ages, with the proportion of first births among women aged 30-34 and 35+ steadily increasing from 2016 to 2023, highlighting delayed parenthood and supporting the growing demand for fertility testing devices.
In addition to delayed parenthood, lifestyle factors significantly impact reproductive health for both men and women. High stress levels, irregular sleep patterns, poor dietary habits, limited physical activity, and smoking reduce fertility in men and women. Smoking in men has been linked to reduced sperm count, motility, and overall semen quality, while in women, it affects ovarian reserve and conception rates. For instance, as per the Global Action to End Smoking, in 2022, approximately 253.0 million individuals (200.2 million males and 53.5 million females) aged 15 and above were users of tobacco products in India. These lifestyle challenges have led many individuals to actively monitor their reproductive health through home-based and non-invasive fertility testing devices.
Furthermore, the increasing prevalence of infertility worldwide has boosted demand for fertility testing devices for both men and women. A WHO report published in 2023 states that about 17.5% of adults, roughly 1 in 6 people globally, face infertility, emphasizing the critical need for improved access to affordable, high-quality care for those affected. Contributing factors include hormonal imbalances, reproductive conditions like polycystic ovary syndrome (PCOS) in women, and decreasing sperm quality in men.
Global Fertility Testing Devices Market Report Segmentation
This report forecasts revenue growth and provides at global, regional, and country levels an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global fertility testing devices market report based on product, application, end-use, and region: